The Dynamics of Angiogenic Factors and Their Soluble Receptors in Relation to Organ Dysfunction in Disseminated Intravascular Coagulation Associated with Sepsis

[1]  Alison Fox-Robichaud,et al.  Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis* , 2011, Critical care medicine.

[2]  E. V. de Paula,et al.  Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study , 2011, Journal of Translational Medicine.

[3]  R. Perng,et al.  Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study , 2011, Critical care.

[4]  M. Molyneux,et al.  The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children , 2010, Critical care.

[5]  J. Bae,et al.  Thrombin upregulates the angiopoietin–Tie2 Axis: endothelial protein C receptor occupancy prevents the thrombin mobilization of angiopoietin 2 and P‐selectin from Weibel–Palade bodies , 2010, Journal of thrombosis and haemostasis : JTH.

[6]  V. V. van Hinsbergh,et al.  THE INTERACTION OF SOLUBLE TIE2 WITH ANGIOPOIETINS AND PULMONARY VASCULAR PERMEABILITY IN SEPTIC AND NONSEPTIC CRITICALLY ILL PATIENTS , 2010, Shock.

[7]  Satoshi Gando,et al.  Microvascular thrombosis and multiple organ dysfunction syndrome , 2010, Critical care medicine.

[8]  Gavin Thurston,et al.  Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system , 2009, Nature Reviews Molecular Cell Biology.

[9]  D. Fliser,et al.  Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients , 2008, Critical care.

[10]  E. Ruokonen,et al.  Vascular Endothelial Growth Factor in Severe Sepsis and Septic Shock , 2008, Anesthesia and analgesia.

[11]  D. Angus,et al.  A PROSPECTIVE, OBSERVATIONAL STUDY OF SOLUBLE FLT-1 AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN SEPSIS , 2008, Shock.

[12]  S. Kushimoto,et al.  Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey* , 2008, Critical care medicine.

[13]  J. Carcillo,et al.  ADMISSION ANGIOPOIETIN LEVELS IN CHILDREN WITH SEPTIC SHOCK , 2007, Shock.

[14]  F. Hsieh,et al.  Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis , 2007, Critical care medicine.

[15]  C. Roussos,et al.  Angiopoietin‐2 is increased in severe sepsis: Correlation with inflammatory mediators , 2007, Critical care medicine.

[16]  H. Augustin,et al.  Angiopoietins: a link between angiogenesis and inflammation. , 2006, Trends in immunology.

[17]  P. Carmeliet,et al.  Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality , 2006, The Journal of experimental medicine.

[18]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[19]  K. Alitalo,et al.  Signaling and Functions of Angiopoietin-1 in Vascular Protection , 2006, Circulation research.

[20]  P. Pickkers,et al.  VASCULAR ENDOTHELIAL GROWTH FACTOR IS INCREASED DURING THE FIRST 48 HOURS OF HUMAN SEPTIC SHOCK AND CORRELATES WITH VASCULAR PERMEABILITY , 2005, Shock.

[21]  M. Shibuya,et al.  The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. , 2005, Clinical science.

[22]  J. Kimpen,et al.  PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR IN SEVERE SEPSIS , 2005, Shock.

[23]  N. Tsopanoglou,et al.  Role of thrombin in angiogenesis and tumor progression. , 2004, Seminars in thrombosis and hemostasis.

[24]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[25]  W. Sessa,et al.  Angiopoietin‐1 negatively regulates expression and activity of tissue factor in endothelial cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  F B Taylor,et al.  Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.

[27]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.

[28]  K. Suzuma,et al.  Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[29]  M. Bottomley,et al.  Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. , 1998, Clinical science.

[30]  H. Verheul,et al.  Platelet: transporter of vascular endothelial growth factor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  S. Rafii,et al.  Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[33]  J. L. Gall,et al.  APACHE II--a severity of disease classification system. , 1986, Critical care medicine.

[34]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[35]  L. Díaz-Flores,et al.  [Disseminated intravascular coagulation]. , 1977, Actas dermo-sifiliograficas.

[36]  G. Martiny-Baron,et al.  Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood , 2004, Angiogenesis.

[37]  G. Hospers,et al.  Platelets and Granulocytes, in Particular the Neutrophils, Form Important Compartments for Circulating Vascular Endothelial Growth Factor , 2004, Angiogenesis.

[38]  M. Nakamura,et al.  Endothelial cell dysfunction in microvasculature: relevance to disease processes. , 2000, Clinical hemorheology and microcirculation.